Seelos Therapeutics Inc (SEEL)
3.41
+0.41
(+13.67%)
USD |
NASDAQ |
Oct 04, 16:00
3.42
+0.01
(+0.29%)
After-Hours: 20:00
Seelos Therapeutics Shareholders Equity (Annual): -33.51M for Dec. 31, 2023
Shareholders Equity (Annual) Chart
Historical Shareholders Equity (Annual) Data
| Date | Value |
|---|---|
| December 31, 2023 | -33.51M |
| December 31, 2022 | -10.61M |
| December 31, 2021 | 57.32M |
| December 31, 2020 | 2.572M |
| December 31, 2019 | -0.007M |
| December 31, 2018 | 2.572M |
| December 31, 2017 | 4.371M |
| December 31, 2016 | -7.516M |
| December 31, 2015 | -9.944M |
| December 31, 2014 | 1.919M |
| December 31, 2013 | 10.97M |
| December 31, 2012 | 6.621M |
| December 31, 2011 | 4.818M |
| December 31, 2010 | 11.57M |
| Date | Value |
|---|---|
| December 31, 2009 | 2.705M |
| December 31, 2008 | 1.532M |
| December 31, 2007 | 4.805M |
| December 31, 2006 | 11.50M |
| December 31, 2005 | 0.6404M |
| December 31, 2004 | 11.40M |
| December 31, 2003 | 12.72M |
| December 31, 2002 | 3.224M |
| December 31, 2001 | 24.11M |
| December 31, 2000 | 38.74M |
| December 31, 1999 | 6.90M |
| December 31, 1998 | -2.390M |
| December 31, 1997 | -0.9263M |
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Annual) Range, Past 5 Years
-33.51M
Minimum
2023
57.32M
Maximum
2021
3.153M
Average
-0.007M
Median
2019
Shareholders Equity (Annual) Benchmarks
| 180 Life Sciences Corp | -0.1277M |
| Cassava Sciences Inc | 137.47M |
| Cara Therapeutics Inc | 57.08M |
| Citius Pharmaceuticals Inc | 90.83M |
| Moleculin Biotech Inc | 26.07M |